Psoriasisban szenvedo betegek életminoségének vizsgálata Magyarországon

Translated title of the contribution: Assessment of health-related quality of life in psoriasis patients in Hungary

Poór Adrienn Katalin, Sárdy Miklós, Cserni Tamás, Brodszky Valentin, Holló Péter, L. Gulácsi, E. Remenyik, Szegedi Andrea, Rencz Fanni, Péntek Márta

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Introduction: The health status and health-related quality of life (HRQoL) of patients with psoriasis in Hungary are understudied. Aim: To assess HRQoL in psoriasis patients, to compare HRQoL of psoriasis patients to that of the general public in Hungary and to identify predictors of HRQoL. Method: Between 2012 and 2016, two cross-sectional surveys were carried out among psoriasis patients at two academic dermatology departments. HRQoL was assessed by EQ-5D-3L, EQ Visual Analogue Scale (EQ VAS) and Dermatology Life Quality Index (DLQI). Predictors of HRQoL were analysed by multivariate linear regression. Results: 434 patients were enrolled (mean age 49 years, 65% male, 81% moderate-to-severe psoriasis, 43% treated with biologics). Mean EQ-5D-3L, EQ VAS and DLQI scores were 0.74 ± 0.28, 69.06 ± 20.98 and 6.78 ± 7.38, respectively. Overall, 54%, 43%, 40%, 32% and 15% of patients indicated at least some problems in pain/discomfort, anxiety/depression, mobility, usual activities and self-care. EQ-5D-3L index scores in patients were lower compared to the age- and gender-matched general population in Hungary. The difference was statistically significant for the age groups 25-34 and 45-64 in males, and 18-64 in females (p<0.05). Female gender (p = 0.042), psoriatic arthritis (p<0.001) and palmoplantar psoriasis (p = 0.031) were associated with lower EQ-5D-3L index scores. On the contrary, employed and highly educated patients reported higher EQ-5D-3L index scores (p<0.001). Conclusions: We were the first to assess HRQoL in psoriasis patients by using EQ-5D questionnaire in Hungary, and more broadly in Central and Eastern Europe. Our findings are useful for cost-effectiveness modelling of psoriasis treatments and decision-making in healthcare.

Translated title of the contributionAssessment of health-related quality of life in psoriasis patients in Hungary
Original languageHungarian
Pages (from-to)837-846
Number of pages10
JournalOrvosi Hetilap
Volume159
Issue number21
DOIs
Publication statusPublished - May 1 2018

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Assessment of health-related quality of life in psoriasis patients in Hungary'. Together they form a unique fingerprint.

  • Cite this

    Katalin, P. A., Miklós, S., Tamás, C., Valentin, B., Péter, H., Gulácsi, L., Remenyik, E., Andrea, S., Fanni, R., & Márta, P. (2018). Psoriasisban szenvedo betegek életminoségének vizsgálata Magyarországon. Orvosi Hetilap, 159(21), 837-846. https://doi.org/10.1556/650.2018.31061